CPB2-AS1
Basic information
Region (hg38): 13:46052497-46161379
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
- Inborn genetic diseases (20 variants)
- not provided (6 variants)
- Hereditary breast ovarian cancer syndrome (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the CPB2-AS1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 0 | |||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 20 | 27 | ||||
Total | 1 | 0 | 20 | 2 | 4 |
Variants in CPB2-AS1
This is a list of pathogenic ClinVar variants found in the CPB2-AS1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
13-46053665-T-A | not specified | Likely benign (Jun 07, 2024) | ||
13-46053671-A-G | CPB2-related disorder | Likely benign (Aug 14, 2019) | ||
13-46053702-A-G | not specified | Uncertain significance (Feb 14, 2023) | ||
13-46055768-T-C | not specified | Uncertain significance (Jan 20, 2023) | ||
13-46055809-A-G | CPB2-related disorder | Benign (Oct 17, 2019) | ||
13-46055831-C-T | not specified | Uncertain significance (Dec 07, 2022) | ||
13-46055843-C-A | not specified | Uncertain significance (Jul 25, 2023) | ||
13-46064691-G-A | CPB2-related disorder | Benign (Nov 19, 2019) | ||
13-46064707-G-A | not specified | Uncertain significance (Jul 05, 2023) | ||
13-46064709-A-G | Likely benign (Apr 04, 2018) | |||
13-46067331-A-G | CPB2-related disorder | Benign (Oct 17, 2019) | ||
13-46067346-T-C | CPB2-related disorder | Benign (Oct 16, 2019) | ||
13-46067399-TC-T | CPB2-related disorder | Uncertain significance (Jul 30, 2024) | ||
13-46073912-T-C | CPB2-related disorder | Likely benign (Jun 18, 2019) | ||
13-46073959-C-T | CPB2-related disorder | Benign (Oct 17, 2019) | ||
13-46078860-A-G | Benign (Jul 16, 2018) | |||
13-46078900-A-G | not specified | Uncertain significance (Dec 09, 2023) | ||
13-46082472-G-A | not specified | Uncertain significance (Jul 14, 2023) | ||
13-46082476-C-A | not specified | Likely benign (Oct 20, 2023) | ||
13-46082511-T-C | not specified | Uncertain significance (Mar 15, 2024) | ||
13-46082534-A-G | CPB2-related disorder | Benign (Oct 16, 2019) | ||
13-46084226-G-A | not specified | Uncertain significance (Jan 17, 2024) | ||
13-46084238-C-T | not specified | Uncertain significance (Mar 05, 2024) | ||
13-46084297-T-G | not specified | Uncertain significance (Aug 04, 2023) | ||
13-46087824-G-C | Likely benign (Jul 16, 2018) |
GnomAD
Source:
dbNSFP
Source: